Chordate Medical Holding AB

Equities

CMH

SE0009495559

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm Other stock markets 08:59:45 31/05/2024 pm IST			5-day change	1st Jan Change
0.0522 ^SEK	-2.97%		+6.10%	-67.46%

24/05	Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
07/05	Chordate Medical Receives Patent Approval in the US	CI

Otto Skolling Elected to Chordate Medical's Board

June 15, 2023 at 12:30 pm IST

Chordate Medical announced that Otto Skolling was elected Vice Chairman of the Board. Otto Skolling has over 30 years of experience in product development, business development and project management within the pharmaceutical and medical technology industry. BioStock contacted Otto Skolling to find out more about his expectations for the role as Vice Chairman of the Board of Chordate Medical.

Latest news about Chordate Medical Holding AB

Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	24/05	CI
Chordate Medical Receives Patent Approval in the US	07/05	CI
Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/03	CI
Chordate Medical Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/03	CI
Chordate Medical Gains EU Patent for Chronic Migraine Treatment	02/02	MT
Chordate Medical Holding AB Announces the European Patent Office Grants New Patent	02/02	CI
Chordate Medical Holding AB Signs Agreement with German Clinic for the Ozilia Treatment for Chronic Migraine	30/01	CI
Chordate Medical Completes Training of Clinic Staff and Assists in Initiation of Treatment for First Three Patients at the Private Clinic in Hamburg	10/01	CI
Chordate Medical Holding AB Announces First Patients Included in the Post-Market Study PM010	21/12	CI
Chordate Medical Holding AB Announces First Patient Included in the Company's Open Pilot Study PM009	04/12	CI
Chordate Medical Holding AB Receives First Installation of the Ozilia Migraine Treatment at a Private Clinic in Hamburg	28/11	CI
Chordate Medical Holding AB Announces Post-Market Study of Chordate's Ozilia® Migraine Treatment Has Commenced in Four Different Markets	10/11	CI
Chordate Medical Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	01/11	CI
Chordate Medical Trademarks Migraine Treatment Ozilia in EU	27/23/27	MT
Chordate Medical Receives Registration of the Tradark Ozilia	27/23/27	CI
Chordate Medical Holding AB Introduces New Trademark for Migraine Treatment: Ozilia? - Migraine Relief	11/23/11	CI
Chordate Medical Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/23/31	CI
Chordate Medical Holding AB Announces Complete Study Results from Migraine Study Submitted to Scientific Journal	21/23/21	CI
Otto Skolling Elected to Chordate Medical's Board	15/23/15	CI
Study Shows Positive Effects of Chordate Medical's Treatment for Allergic Rhinitis	29/23/29	MT
Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
Chordate Medical Holding AB Appoints Otto Skolling as New Vice Chairman of the Board of Directors	11/23/11	CI
UK's National Health Service Grants Ethical Approval for Chordate Medical Migraine Study	05/23/05	MT
NHS Gives Ethical Approval for Chordate's New Migraine Study	05/23/05	CI
Chordate Medical Presents Study Results for the American Headache Society	19/23/19	CI

Chart Chordate Medical Holding AB

Duration

Period

More charts

Company Profile

Chordate Medical Holding AB (publ) is a medical technology company based in Sweden. The Company develops treatment method through nerve stimulation for chronic nasal congestion. The Companyâs headquartered is located in Kista, Sweden.

Sector

Advanced Medical Equipment & Technology

Calendar

30/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
CHORDATE MEDICAL HOLDING AB	-67.46%	2.42M
THERMO FISHER SCIENTIFIC	+7.01%	217B
DANAHER CORPORATION	+11.01%	190B
INTUITIVE SURGICAL, INC.	+19.20%	143B
BOSTON SCIENTIFIC CORPORATION	+30.79%	111B
SIEMENS HEALTHINEERS AG	+1.48%	64.59B
EDWARDS LIFESCIENCES CORPORATION	+13.95%	52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.16%	48.45B
AGILENT TECHNOLOGIES, INC.	-6.20%	38.03B
GE HEALTHCARE TECHNOLOGIES INC.	+0.91%	35.6B

Other Advanced Medical Equipment & Technology